Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.
about
Infection with and Carriage of Mycoplasma pneumoniae in ChildrenAnti-alpha-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological eventAntibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis.The structural and functional role of myelin fast-migrating cerebrosides: pathological importance in multiple sclerosis.Progress in multiple sclerosis genetics.Toward biomarkers in multiple sclerosis: new advances.Anti-glycan antibodies as biomarkers for diagnosis and prognosis.Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental designInterferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab.Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?Early treatment of multiple sclerosis: a Latin American experts meeting.Pathogenic and physiological autoantibodies in the central nervous system.Quantified CSF antibody reactivity against myelin in multiple sclerosis.Antibodies to myelin P0 and ceramide perpetuate neuropathy in long standing treated leprosy patients.Myelin glycosphingolipid immunoreactivity and CSF levels in multiple sclerosis.
P2860
Q26752332-5ADE9DD5-56E9-4567-AEEC-CA4E54E3A09CQ33773528-80F1213E-44EF-46B3-8481-8F7752BC802FQ34479121-341F54E8-522E-4C1F-98E4-E30A5D7122AEQ34652734-CC2C44FF-56E5-4E33-81F1-357A9A658850Q36027486-544B3E3C-0086-4EA6-958C-84B1CE892B8FQ36382352-1F9B8BBC-1083-4CCC-B9BC-38515E2202C9Q36492380-04480B71-8D57-4760-93A7-04226072B982Q36560795-3747FA0F-9470-4742-BCFD-1E6B148C5B55Q36887316-CB17ADEB-9E13-4F15-9B6F-134E9A332031Q37243842-48AFFB02-1838-4A95-9BC9-0FCACBA4588DQ37389500-8C3EB6F9-1F90-45AE-A4E4-4AB20E01B9BBQ37582663-48B86692-E7E5-4A03-B50C-8733818AE385Q37645629-FF6A420F-1C13-42EB-B059-BACB57DFE690Q38020957-413D8026-64BD-4B9A-952B-C6E76AC50D82Q43113841-81DDEFB9-0E20-40C0-B912-C0C6E179EAFAQ44724531-3586E850-4BE1-425D-9E96-FBB768A58BAEQ49122634-A76E4D62-C2B4-4817-B456-8B892AC032E2
P2860
Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Antibody responses against gal ...... markers in multiple sclerosis.
@en
Antibody responses against gal ...... markers in multiple sclerosis.
@nl
type
label
Antibody responses against gal ...... markers in multiple sclerosis.
@en
Antibody responses against gal ...... markers in multiple sclerosis.
@nl
prefLabel
Antibody responses against gal ...... markers in multiple sclerosis.
@en
Antibody responses against gal ...... markers in multiple sclerosis.
@nl
P2093
P921
P1476
Antibody responses against gal ...... omarkers in multiple sclerosis
@en
P2093
Bruce Cree
Claude P Genain
Patrice H Lalive
Stephen L Hauser
P304
P356
10.1016/J.JACI.2005.03.023
P407
P577
2005-08-01T00:00:00Z